- Report
- August 2025
- 191 Pages
Global
From €3112EUR$3,545USD£2,707GBP
€3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 189 Pages
Global
From €3112EUR$3,545USD£2,707GBP
€3458EUR$3,939USD£3,008GBP
- Report
- September 2025
- 250 Pages
Global
From €3942EUR$4,490USD£3,429GBP
- Report
- December 2024
- 125 Pages
Global
From €4082EUR$4,650USD£3,551GBP
- Report
- August 2025
- 193 Pages
Global
From €3112EUR$3,545USD£2,707GBP
€3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 184 Pages
Global
From €3112EUR$3,545USD£2,707GBP
€3458EUR$3,939USD£3,008GBP
- Report
- March 2025
- 200 Pages
Global
From €2186EUR$2,490USD£1,902GBP
- Report
- September 2025
- 250 Pages
Global
From €3942EUR$4,490USD£3,429GBP
- Report
- August 2025
- 187 Pages
Global
From €3112EUR$3,545USD£2,707GBP
€3458EUR$3,939USD£3,008GBP
- Report
- April 2025
- 200 Pages
Global
From €6980EUR$7,950USD£6,071GBP
- Report
- September 2025
- 189 Pages
Global
From €5136EUR$5,850USD£4,467GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2634EUR$3,000USD£2,291GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2634EUR$3,000USD£2,291GBP
- Report
- February 2025
- 150 Pages
Global
From €2633EUR$2,999USD£2,290GBP
- Report
- June 2025
- 150 Pages
Global
From €2370EUR$2,699USD£2,061GBP
- Report
- June 2025
- 400 Pages
Global
From €4345EUR$4,949USD£3,779GBP
- Report
- July 2025
- 200 Pages
United States
From €2186EUR$2,490USD£1,902GBP
- Report
- December 2022
- 196 Pages
Global
From €4700EUR$5,541USD£3,950GBP
- Report
- June 2025
- 110 Pages
United Kingdom
From €4346EUR$4,950USD£3,780GBP
- Report
- June 2023
- 103 Pages
Global
From €5224EUR$5,950USD£4,544GBP

Galantamine is a drug used to treat mild to moderate Alzheimer's Disease. It is an acetylcholinesterase inhibitor, meaning it works by increasing the amount of the neurotransmitter acetylcholine in the brain. This helps to improve memory, thinking, and behavior in people with Alzheimer's. Galantamine is available in both oral and intravenous forms, and is often used in combination with other Alzheimer's medications. It is generally well-tolerated, with the most common side effects being nausea, vomiting, and diarrhea.
Galantamine is one of several drugs used to treat Alzheimer's Disease, and is often prescribed alongside other medications such as donepezil and memantine. It is available in generic form, as well as under the brand names Razadyne and Reminyl.
Companies in the Galantamine market include Janssen Pharmaceuticals, Eisai Co., Ltd., and Shire Pharmaceuticals. Show Less Read more